Chicago, IL49 Active Studies

Ulcerative Colitis Clinical Trials in Chicago, IL

Find 49 actively recruiting ulcerative colitis clinical trials in Chicago, IL. Connect with local research sites and explore new treatment options.

49
Active Trials
39
Sponsors
13,785
Enrolling

Recruiting Ulcerative Colitis Studies in Chicago

About Ulcerative Colitis Clinical Trials in Chicago

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 49 ulcerative colitis clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 13,785 participants. Research is being sponsored by University of Colorado, Denver, The George Washington University Biostatistics Center, Inozyme Pharma and 36 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Chicago — FAQ

Are there ulcerative colitis clinical trials in Chicago?

Yes, there are 49 ulcerative colitis clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 49 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 16, 2026 from ClinicalTrials.gov